Recombinant DNA Study Guide

📖 Core Concepts Recombinant DNA (rDNA) – DNA assembled in the lab from two or more genetic sources; often called chimeric DNA. Molecular cloning – The laboratory process of inserting a DNA fragment into a cloning vector, introducing it into a host cell, and letting the cell replicate the recombinant molecule. Cloning vector – A DNA carrier (usually a plasmid or virus) that can replicate in a host and carries: Origin of replication (Ori) – enables autonomous replication. Selectable marker – antibiotic resistance or other trait to identify transformed cells. Expression signals (optional) – promoter, ribosome‑binding site, terminator. Restriction enzymes – Molecular scissors that cut DNA at specific palindromic sites, generating sticky ends (overhangs) or blunt ends. DNA ligase – Enzyme that joins compatible DNA ends, forming phosphodiester bonds. Gibson assembly – One‑tube, isothermal method that uses exonuclease, polymerase, and ligase to fuse multiple fragments with overlapping ends. Gene restructuring for expression – Adding a promoter, translation initiation signal (e.g., Shine‑Dalgarno or Kozak), and transcription terminator to a foreign gene. Codon optimization – Re‑designing the coding sequence to match the host’s preferred codon usage, boosting translation efficiency. Recombinant protein – Protein produced by a host cell after it expresses introduced rDNA. --- 📌 Must Remember rDNA can be made from any species because DNA chemistry is universal. Cloning ≠ PCR: cloning replicates DNA in vivo; PCR amplifies DNA in vitro (no cells). Vector choice depends on host, insert size, and need for expression. Sticky ends → higher ligation efficiency than blunt ends. Gibson assembly is ideal for joining ≥3 fragments simultaneously. Promoter + initiation signal + terminator are mandatory for transcription/translation. Codon bias: mismatch → slower translation, possible misfolding. Detection: RNA → RT‑PCR. Protein → Western blot, ELISA. Phenotype of rDNA carriers is usually normal; toxicity appears only with over‑expression or inappropriate tissue expression. Insertional inactivation can be used deliberately for gene knockouts. First FDA‑approved recombinant drug: human insulin (E. coli/yeast). --- 🔄 Key Processes Standard Molecular Cloning Isolate DNA fragment of interest. Digest both fragment and vector with compatible restriction enzymes → generate sticky/blunt ends. Dephosphorylate vector (optional) to reduce self‑ligation. Ligate fragment into vector with DNA ligase. Transform competent host cells (e.g., E. coli). Select transformants on antibiotic plates (marker). Screen/confirm insert (colony PCR, restriction analysis, sequencing). Gibson Assembly (multi‑fragment) Design fragments with 15–40 bp overlaps. Mix fragments with Gibson master mix (exonuclease, polymerase, ligase). Incubate 50 °C (30–60 min). Transform assembled plasmid into host and follow steps 5‑7 above. Expression of Recombinant Protein Choose host (bacteria, yeast, insect, mammalian) based on required PTMs. Transfect or transform host with expression vector. Induce expression (e.g., IPTG for E. coli). Harvest cells; lyse if intracellular, collect medium if secreted. Detect RNA (RT‑PCR) and protein (Western blot/ELISA). --- 🔍 Key Comparisons Recombinant DNA vs PCR rDNA: assembled in cells, can be propagated, may include expression elements. PCR: amplifies existing DNA in a tube, no cellular replication. Sticky ends vs Blunt ends Sticky: complementary overhangs → higher ligation efficiency, directional cloning. Blunt: no overhangs → lower efficiency, useful when restriction sites are unavailable. Bacterial vs Mammalian host Bacterial: fast growth, inexpensive, no complex PTMs (glycosylation). Mammalian: proper folding/PTMs, higher cost, slower growth. E. coli vs Yeast for insulin E. coli: produces pro‑insulin, requires refolding; no glycosylation. Yeast: can perform limited PTMs, often yields secreted insulin precursor. --- ⚠️ Common Misunderstandings “Any promoter works in any host.” Promoters are species‑specific; bacterial promoters fail in mammalian cells. “Plasmid replication is automatic in any cell.” The plasmid’s Ori must be recognized by the host’s replication machinery. “Over‑expressing a protein always yields more product.” Excessive protein can be toxic, form inclusion bodies, or burden the host. “Detection of RNA guarantees functional protein.” Transcription does not ensure proper translation, folding, or activity. “All recombinant proteins are immunogenic.” Many are designed to be non‑immunogenic (e.g., human insulin). --- 🧠 Mental Models / Intuition DNA LEGO bricks – Restriction enzymes cut bricks; ligase snaps them together. Vector as a delivery truck – Carries the cargo (insert) into the host city (cell). Promoter = “ON switch” – Without it, the gene stays dark; with it, transcription starts. Codon usage = “language dialect” – Host reads the “dialect” most efficiently; speak its dialect for smoother translation. --- 🚩 Exceptions & Edge Cases Expression failure despite promoter – caused by codon bias, mRNA instability, or missing upstream regulatory elements. Protein toxicity – Some enzymes (e.g., proteases) kill the host even at low levels. Insertional activation – A strong promoter in the vector can unintentionally turn on a neighboring host gene. Post‑translational modification – Bacterial hosts cannot add disulfide bonds or glycosylation required for some eukaryotic proteins. --- 📍 When to Use Which | Situation | Recommended Choice | |-----------|--------------------| | Small insert (<10 kb), need fast cloning | Standard restriction‑ligation with a high‑copy plasmid. | | Multiple fragments (≥3) or seamless junctions | Gibson assembly (or other seamless methods). | | Protein requires eukaryotic PTMs | Mammalian or insect cell expression system. | | Cost‑sensitive, simple protein | E. coli with a bacterial expression vector. | | Need secretion into media | Include a signal peptide; use yeast or mammalian cells. | | Host‑specific selectable marker needed | Choose vector with antibiotic resistance compatible with host (e.g., ampicillin for E. coli, hygromycin for mammalian). | | Avoiding vector backbone recombination | Use blunt‑end cloning or recombination‑deficient host strains. | --- 👀 Patterns to Recognize Selectable marker + correct antibiotic → successful transformants. Signal peptide at N‑terminus → protein likely secreted. High GC‑content region + rare codons → possible low expression in bacterial host. Growth slowdown after induction → potential toxicity or inclusion‑body formation. PCR product size matches vector + insert → correct cloning. --- 🗂️ Exam Traps “PCR can generate recombinant plasmids.” – PCR amplifies DNA but does not create circular, replicating plasmids in cells. “All vectors contain promoters for protein expression.” – Many cloning vectors are non‑expressing; expression vectors are a subset. “Sticky ends guarantee correct orientation.” – Only if two different restriction sites are used (directional cloning). “Recombinant proteins always trigger immune responses.” – Human proteins expressed recombinantly (e.g., insulin) are non‑immunogenic. “Insertional inactivation only occurs accidentally.” – It is a deliberate strategy for gene knockout studies. “Yeast can perform any human PTM.” – Yeast lack some complex mammalian glycosylation pathways; choose mammalian cells for fully humanized proteins. ---